Parkinson’s disease (PD) is a neurodegenerative disorder that is predicted to affect 930,000 people by the end of 2020 and 1.2 million by 2030. The disease triggers tremors, slowing movements, balance problems and rigidity. There is no known cause or cure and the first line of treatment usually involves drugs that don’t slow the associated… Read More »
A promising molecule has offered hope for a new treatment that could stop or slow Parkinson’s, something no treatment can currently do. Researchers from the University of Helsinki found that molecule BT13 has the potential to both boost levels of dopamine, the chemical that is lost in Parkinson’s, as well as protect the dopamine-producing brain… Read More »
WEDNESDAY, Feb. 5, 2020 — People who develop Parkinson’s disease at a younger age (before age 50) may have malfunctioning brain cells at birth, according to a study that also identified a drug that may help these patients. At least 500,000 people in the United States are diagnosed with Parkinson’s each year. Most are 60… Read More »
A new study using a roundworm model of Parkinson’s disease found that a probiotic bacterium could prevent, and in some cases reverse, toxic protein buildup. Misfolded alpha-synuclein proteins in the brain are the hallmark sign of Parkinson’s disease. Many experts believe that these toxic protein clumps lead to the progressive loss of brain cells that… Read More »
A new study shows that pulses of minimally invasive ultrasound waves improve the quality of life for people living with Parkinson’s disease by immediately and significantly reducing tremors. Share on PinterestA new technique may help reduce tremors in Parkinson’s disease. The study involved a minimally invasive procedure that offers significant benefits over some other treatments… Read More »
Parkinson’s is a progressive neurological condition. It causes problems in the brain that gets worse over time. The number of people diagnosed with Parkinson’s in the UK is about 145,000, which is around one adult in every 350. A person who suffers from Parkinson’s doesn’t have enough of the chemical dopamine because some of the… Read More »
Parkinson’s disease, a neurodegenerative disorder that affects more than 6 million people worldwide, is caused by the buildup of alpha-synuclein proteins in the brain. The biological function of alpha-synuclein is still not well understood, but because of its role in neurodegenerative diseases, researchers are actively studying this protein to understand the mechanisms of the disease… Read More »